Ram Selvaraju Profile - H.C. Wainwright Analyst
16,496 Followers
Ram Selvaraju's Stock Coverage
| SPRBSpruce Biosciences | Nov 13, 2026 | BUY | Reiterated | $150.00 | 23Ratings | -33.22% | ||
| INVAInnoviva | Nov 13, 2026 | BUY | Reiterated | $46.00 | 10Ratings | -5.27% | ||
| IKTInhibikase Therapeutics | Nov 13, 2026 | BUY | Reiterated | $8.00 | 8Ratings | -13.38% | ||
| COYACoya Therapeutics, Inc. | Nov 13, 2026 | BUY | Reiterated | $18.00 | 22Ratings | -28.51% | ||
| IDIAIdorsia Ltd | Nov 13, 2026 | BUY | Reiterated | CHF6.00 | 58Ratings | +4.80% | ||
| BSLNBasilea Pharmaceutica | Nov 13, 2026 | BUY | Reiterated | CHF120.00 | 45Ratings | +20.83% | ||
| ABEOAbeona Therapeutics | Nov 13, 2026 | BUY | Reiterated | $18.00 | 89Ratings | -36.91% | ||
| TRDAEntrada Therapeutics Inc | Nov 12, 2026 | HOLD | Reiterated | ― | 22Ratings | -16.50% | ||
| INOInovio Pharmaceuticals | Nov 12, 2026 | BUY | Reiterated | $5.00 | 154Ratings | -22.70% | ||
| GANXGain Therapeutics | Nov 12, 2026 | BUY | Reiterated | $8.00 | 34Ratings | -25.11% |
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed. See how TipRanks ranks experts and calculates performance.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >Ram Selvaraju activity FAQ
What is the performance of Ram Selvaraju's recommendations?
The percentage of profitable recommendations made by Ram Selvaraju is 39.80%, and the average return per transaction is 2.40%.
What stocks does Ram Selvaraju cover?
What was Ram Selvaraju's most profitable rating?
Ram Selvaraju’s most profitable rating was a buy on Ovid Therapeutics stock on May 27, 2025. The return on the trade was 772.80%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here
